Pulseless ventricular tachycardia other diagnostic studies

Jump to navigation Jump to search

Pulseless ventricular tachycardia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pulseless ventricular tachycardia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography

Cardiac MRI

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pulseless ventricular tachycardia other diagnostic studies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pulseless ventricular tachycardia other diagnostic studies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pulseless ventricular tachycardia other diagnostic studies

CDC on Pulseless ventricular tachycardia other diagnostic studies

Pulseless ventricular tachycardia other diagnostic studies in the news

Blogs on Pulseless ventricular tachycardia other diagnostic studies

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Pulseless ventricular tachycardia other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aisha Adigun, B.Sc., M.D.[2]

Overview

2017 guidelines from the AHA/ACC/HRS state that MRI, cardiac computed tomography (CT), or radionuclide angiography can be useful in detecting and characterizing underlying heart disease when echocardiography fails to provide an accurate evaluation of LV or RV function and/or assessment of structural changes. Electrophysiologic (EP) testing can be useful when an uncertain diagnosis of sustained monomorphic ventricular tachycardia. An electrophysiological study is especially useful for assessing the risk of ventricular tachycardia in patients with ischemic cardiomyopathy, non-ischemic cardiomyopathy, or adult congenital heart disease who have syncope or other ventricular arrhythmia symptoms and who do not meet indications for a primary prevention implantable cardioverter-defibrillator.

Other Diagnostic Studies

  • 2017 guidelines from the AHA/ACC/HRS state that MRI, cardiac computed tomography (CT), or radionuclide angiography can be useful in detecting and characterizing underlying heart disease when echocardiography fails to provide an accurate evaluation of LV or RV function and/or assessment of structural changes.
  • Coronary angiography is used in the diagnostic evaluation of ventricular tachycardia in survivors of sudden cardiac death and life-threatening ventricular tachycardia.
  • Coronary angiography is used to rule out the presence of coronary artery disease in these patients.[1]
  • Electrophysiologic (EP) testing can be useful when an uncertain diagnosis of sustained monomorphic ventricular tachycardia.
  • An electrophysiological study is especially useful for assessing the risk of ventricular tachycardia in patients with certain conditions who have syncope or other ventricular arrhythmia symptoms and who do not meet indications for a primary prevention implantable cardioverter-defibrillator. These conditions include;
    • Ischemic cardiomyopathy,
    • Non-ischemic cardiomyopathy,
    • Adult congenital heart disease.

2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death[2]

Left Ventricular Function and Imaging (DO NOT EDIT)[2]

Class I
"1.In patients who have recovered from unexplained sudden cardiac arrythmis, '''CT''' or invasive '''coronary angiography''' is useful to confirm the presence or absence of ischemic heart disease and guide decisions for myocardial revascularization. (Level of Evidence B)"

Recommendations for Electrophysiological study (DO NOT EDIT)[2]

Class IIa
"1.In patients with ischemic cardiomyopathy, non-ischemic cardiomyopathy, or adultcongenital heart disease who have syncope or other ventricular arrhythmia symptoms and who do not meet indications for a primary prevention implantable cardioverter-defibrillator, an electrophysiological study can be useful for assessing the risk of sustained ventricular tachycardia (Level of Evidence B)"
Class III
"1. In patients who meet criteria for implantable cardioverter-defibrillator implantation, an electrophysiological study for the sole reason of inducing ventricular arrhythmia is not indicated for risk stratification (Level of Evidence B)"
"2.A electrophysiological study is not recommended for risk stratification for ventricular arrhythmia in the setting of long QT syndrome, catecholaminergic polymorphic ventricular tachycardia, short QT syndrome, or early repolarization syndromes (Level of Evidence B)"

References

  1. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M; et al. (2006). "ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society". Circulation. 114 (10): e385–484. doi:10.1161/CIRCULATIONAHA.106.178233. PMID 16935995.
  2. 2.0 2.1 2.2 "www.onlinejacc.org" (PDF).


Template:WH Template:WS